Karani Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,512
| Closed | -$959K | – | 47 |
|
|
2025
Q1 | $959K | Sell |
1,512
-811
| -35% | -$514K | 1.02% | 28 |
|
|
2024
Q4 | $1.65M | Buy |
+2,323
| New | +$1.65M | 1.54% | 22 |
|
|
2023
Q3 | $4.43M | Sell |
5,378
-2,267
| -30% | -$1.87M | 6.37% | 3 |
|
|
2023
Q2 | $5.49M | Sell |
7,645
-230
| -3% | -$165K | 5.54% | 3 |
|
|
2023
Q1 | $6.47M | Buy |
7,875
+135
| +2% | +$111K | 6.85% | 2 |
|
|
2022
Q4 | $5.58M | Sell |
7,740
-2,185
| -22% | -$1.58M | 6.51% | 1 |
|
|
2022
Q3 | $6.84M | Sell |
9,925
-2,085
| -17% | -$1.44M | 6.93% | 1 |
|
|
2022
Q2 | $7.1M | Sell |
12,010
-3,365
| -22% | -$1.99M | 6.56% | 2 |
|
|
2022
Q1 | $10.7M | Buy |
15,375
+415
| +3% | +$290K | 5.81% | 4 |
|
|
2021
Q4 | $9.45M | Buy |
14,960
+3,717
| +33% | +$2.35M | 4.67% | 7 |
|
|
2021
Q3 | $6.8M | Buy |
11,243
+289
| +3% | +$175K | 3.3% | 10 |
|
|
2021
Q2 | $6.12M | Buy |
10,954
+53
| +0.5% | +$29.6K | 3.16% | 19 |
|
|
2021
Q1 | $5.16M | Buy |
10,901
+1,127
| +12% | +$533K | 3.04% | 18 |
|
|
2020
Q4 | $4.72M | Sell |
9,774
-151
| -2% | -$73K | 2.79% | 16 |
|
|
2020
Q3 | $5.56M | Hold |
9,925
| – | – | 3.73% | 5 |
|
|
2020
Q2 | $6.19M | Sell |
9,925
-260
| -3% | -$162K | 4.8% | 4 |
|
|
2020
Q1 | $4.97M | Sell |
10,185
-3,607
| -26% | -$1.76M | 5.32% | 4 |
|
|
2019
Q4 | $5.18M | Buy |
+13,792
| New | +$5.18M | 4.8% | 6 |
|